The Severity of Periodontitis at the Buccal and Palatal Site
Sponsor
The Dental Hospital of Zhejiang University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06031896
Collaborator
(none)
3,000
1
27
111.1
Study Details
Study Description
Brief Summary
To record and compare the periodontal conditions of buccal and palatal sites in patients
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
3000 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
The Comparison of the Severity of Periodontitis at the Buccal and Palatal Site
Anticipated Study Start Date
:
Oct 1, 2023
Anticipated Primary Completion Date
:
Oct 1, 2024
Anticipated Study Completion Date
:
Dec 31, 2025
Outcome Measures
Primary Outcome Measures
- probing depth [3 years]
the probing depth of buccal and palatal sites of teeth in one patient
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- patients with diagnosed periodontitis
Exclusion Criteria:
- compromised systematic health (uncontrolled hypertension, diabetes, impaired bone metabolism condition, etc.), uncontrolled periodontal disease, smoking > 20 cigarettes/day or recent chemotherapy/radiotherapy in the oral and maxillofacial regions
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | The Affiliated Hospital of Stomatology, Zhejiang University School of Medicine | Hangzhou | Zhejiang | China |
Sponsors and Collaborators
- The Dental Hospital of Zhejiang University School of Medicine
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
The Dental Hospital of Zhejiang University School of Medicine
ClinicalTrials.gov Identifier:
NCT06031896
Other Study ID Numbers:
- 2021-116
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: